WHO approves Covaxin vaccine for emergency use
The World Health Organization (WHO) has approved the emergency use of Covaxin. The made-in-India vaccine - Covaxin has been cleared for use in all age groups (18+) over two doses spaced four weeks apart. According to scientists, its efficacy is 77.8% against symptomatic COVID-19 and 65.2% against the new Delta variant.
Covaxin according to WHO is extremely suitable for low and middle-income countries due to easy storage requirements.
Source: BBC News